Check out the companies making headlines in midday trading on Wednesday:
Moderna — Shares of Moderna surged 22.7% to hit an all-time high, after gaining 27.8% just on Tuesday. The rally came after the biotech company said it is hoping for a clinical trial of a coronavirus vaccine by the end of April. The company had shipped a coronavirus vaccine to U.S. government researchers for study.
Guardant Health — Guardant Health spiked 7.5% after the medical company beat analyst earnings and revenue expectations for the fourth quarter. Guardant reported a loss of 27 cents per share and $62.9 million in revenue. Analysts expected a 30 cents per share loss on $54.9 million in revenue, according to FactSet. Canaccord Genuity, which has a buy rating on the stock, said in a note to clients that Guardant's forward guidance seemed conservative and should set the company up for future earnings beats.
Sabre — Shares of Sabre plunged 16.1% after the travel technology company missed revenue expectations for the fourth quarter and said coronavirus would hurt first-quarter revenue by $100 million to $150 million. Sabre reported fourth quarter revenue of $941.4 million, while analysts expected $948 million, according to FactSet. The company also reported a decline in operating income, which it said was due to increased technology expense.
Sinclair Broadcast — Shares of the media conglomerate fell 15% after Sinclair Broadcast reported fourth-quarter earnings of an adjusted 94 cents cents a share, below the $1.02 a share expected according to analysts surveyed by FactSet. Sinclair's media revenue was also notably light, below its previous forecast at $1.58 billion.
TJX Companies — Shares of TJX Companies soared 7.2%. The parent company of TJ Maxx reported adjusted earnings of 81 cents per share and revenue of$12.206 billion for its fourth quarter, with same store sales rising 6%. Wall Street analysts expected adjusted earnings of 77 cents per share and $11.83 billion in revenue, according to Refinitiv.
Netflix — Top technology stocks — also known as the "FAANG" group, the colloquial name for Facebook, Apple, Amazon, Netflix and Google-parent Alphabet — all climbed in trading, with Netflix up 5.3% and leading the group higher. The bounce back for the tech stocks came as the broader U.S. market rebounded after a two day plunge.
B&G Foods — Shares of B&G Foods surged 23.2% after the company reported fourth-quarter earnings in line with Wall Street's expectations, according to FactSet, with a better-than-anticipated forecast for 2020. B&G Foods said it expects to see earnings this year between $1.60 a share and $1.80 a share, with revenue coming in between $1.66 billion and $1.68 billion.
J.M. Smucker — Shares of J.M. Smucker rose 1.3% after beating earnings expectations for its fiscal third quarter. The food company reported $2.35 in adjusted earnings per share for the quarter, topping estimates of $2.23 per share, according to Refinitiv. Its revenues of $1.972 billion matched what analysts expected. Stifel said in a note to client that a legal settlement and lower than expected interest costs helped Smucker's bottom line.
SmileDirectClub — Shares of SmileDirectClub cratered 29.4% following its disappointing fourth quarter results. The company, which sells teeth aligners directly to consumers, reported a loss of 25 cents per share. Revenue came in at $197 million, missing the forecast $200 million in revenue, according to Refinitiv. SmileDirectClub also issued weak full year revenue guidance.
Toll Brothers — shares of the homebuilder plummeted 14.6% after the company missed top and bottom line estimates. In the first quarter, the company earned 41 cents per share on $1.33 billion in revenue. According to estimates from FactSet, analysts had been expecting 46 cents in earnings and $1.44 billion in revenue. Raymond James also lowered its rating on the stock to market perform.
Planet Fitness — Planet Fitness shares slid 6.7% after the gym operator issued weaker-than-forecast earnings guidance for 2020. The company expects full-year earnings per share to come in around $1.84. That's slightly below a Wall Street estimate of $1.90, according to a Wedbush analyst. The disappointing guidance overshadowed better-than-expected results for the fourth quarter.
— CNBC's Maggie Fitzgerald, Yun Li, Pippa Stevens and Fred Imbert contributed to this report.
Subscribe to CNBC PRO for exclusive insights and analysis, and live business day programming from around the world.